Natriuretic peptides during the development of doxorubicin-induced left ventricular diastolic dysfunction

Journal of Internal Medicine

Volumn 251, Issue 3, 2002, Pages 228-234

  Nousiainen, T ^a   Vanninen, E ^a   Jantunen, E ^a   Puustinen, J ^a   Remes, J ^b   Rantala, A ^a   Vuolteenaho, O ^c   Hartikainen, J ^a  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b SATAKUNTA CENTRAL HOSPITAL   (Finland)

^c UNIVERSITY OF OULU   (Finland)

Author keywords

Diastolic; Doxorubicin; Echocardiography; Natriuretic peptides; Systolic

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISOLONE; VINCRISTINE;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DOSE RESPONSE; ECHOCARDIOGRAPHY; FEMALE; HEART EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FILLING PRESSURE; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICLE SIZE; HUMAN; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; PULSE WAVE;

ADULT; AGED; ANTINEOPLASTIC AGENTS; ATRIAL NATRIURETIC FACTOR; DIASTOLE; DOXORUBICIN; FEMALE; HUMANS; LYMPHOMA, NON-HODGKIN; MALE; NATRIURETIC PEPTIDE, BRAIN; PROSPECTIVE STUDIES; PROTEIN PRECURSORS; SYSTOLE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0036124132     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.2002.00951.x     Document Type: Article

References (33)

1. Risk factors for doxorubicin-induced congestive heart failure
2. Doxorubicin-induced cardiomyopathy
3. Anthracycline cardiomyopathy monitored by morphologic changes
4. Congestive heart failure and left ventricular dysfunction complicating doxorubicin therapy. Seven-year experience using serial radionuclide angiocardiography
5. Review of tests for monitoring doxorubicin-induced cardiomyopathy
6. Guidelines for cardiac monitoring of children during and after anthracycline therapy: Report of the Cardiology Committee of the Children's Cancer Study Group
7. Early detection of doxorubicin cardiotoxicity: Interest of Doppler echocardiographic analysis of left ventricular filling dynamics
8. Diastolic or systolic left and right ventricular impairment at moderate doses of anthracycline?
9. Atrial natriuretic peptide: Synthesis, release, and metabolism
10. Natriuretic peptides
11. The propeptide Asn1-Tyr126 is the storage form of rat atrial natriuretic factor
12. Proteolytic processing of atriopeptin pro-hormone
13. Identification of a biologically active circulating form of a rat atrial natriuretic factor
14. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the studies of left ventricular dysfunction (SOLVD)
15. Neuroendocrine activity in untreated heart failure
16. Circulating N-terminal atrial natriuretic peptide as a marker for symptomless left ventricular dysfunction
17. Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide
18. High levels of plasma atrial natriuretic factor and impairmed left-ventricular diastolic function in hypertensives without left ventricular hypertrophy
19. Increased plasma levels of brain natriuretic peptide in patients with isolated diastolic dysfunction
20. Diastolic dysfunction and natriuretic peptides in systolic heart failure
21. Relationship between left ventricular diastolic function and atrial natriuretic factor in never-treated mild hypertensives
22. Associations between atrial natriuretic peptides, echocardiographic findings and mortality in an elderly population sample
23. Natriuretic peptides in patients with diastolic dysfunction due to idiopathic dilated cardiomyopathy
24. Preliminary study on behaviour of atrial natriuretic factor in anthracycline-related cardiac toxicity
25. Natriuretic peptides as markers of cardiotoxicity during doxorubicin treatment for non-Hodgkin's lymphoma
26. Brain natriuretic peptide is a predictor of anthracycline-induced cardiotoxicity
27. Prospective evaluation of early cardiac damage induced by epirubicin-containing adjuvant chemotherapy and locoregional radiotherapy in breast cancer patients
28. Left ventricular function and dimensions in newly diagnosed non-insulin-dependent diabetes mellitus
29. Recommendations regarding quantitation in M-mode echocardiography: Results of a survey of echocardiographic measurements
30. Assessment of left ventricular ejection fraction and volumes by real-time, two-dimensional echocardiography. A comparison of cineangiographic and radionuclide techniques
31. Effect of physical exercise in hypobaric conditions on atrial natriuretic peptide secretion
32. Atrial natriuretic polypeptides (ANP): Rat atria store high molecular weight precursor but secrete processed peptides of 25-35 amino acids
33. Serum N-terminal atrial natriuretic peptide (NT-ANP) in the cardiac follow-up in children with cancer